DENVER, Feb. 13, 2018 /Weed Wire/ – Colorado-based biotech company Next Frontier Biosciences today announced the assembly of its Research and Development Team, enhancing the company’s lineup of accomplished biotechnology executives and research scientists.
Tag Archives: Biotechnology
CLARENCE, N.Y., Oct. 19, 2017 /Weed Wire/ — 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and cannabis research, announced today that the Company and the University of Virginia (“UVA”) completed their first successful harvest of hemp plants and identified several promising hemp varieties that could form the foundation for commercial hemp production throughout the legacy tobacco belt region of the United States.
Gov. Andrew Cuomo has signed legislation that aims to boost hemp production, as Ontario gathers public input on legalizing marijuana.
NANAIMO, British Columbia, Feb. 1, 2017 /Weed Wire/ —Tilray, a global leader in medical cannabis research and production, today announced that it has received necessary regulatory approvals in Canada and Chile to export medical cannabis for distribution to Chilean patients.
Anandia Labs co-founder Jonathan Page agreed to sell 20% of his company to CannaRoyalty because he appreciates CannaRoyalty’s expertise in extraction and post-processing.
GW Pharmaceuticals Plc (Nasdaq:GWPH), a developer of marijuana-based epilepsy treatments, is working with an investment bank after other drugmakers approached it to express interest in an acquisition, people familiar with the matter said.
SAN DIEGO, Aug. 11, 2015 /Weed Wire/ — AXIM Biotechnologies, Inc. (OTC: AXIM) is a unique biotechnology corporation with a focus on global research, development and production of pharmaceutical, nutraceutical, food and cosmetic products – all derived from industrial hemp.